These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32661926)

  • 1. Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO
    Ther Innov Regul Sci; 2021 Jan; 55(1):138-141. PubMed ID: 32661926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study.
    Yin R; Lu J; Xu Z; Yan Q; Wang M; Xu R
    Psychol Health Med; 2023; 28(7):1698-1708. PubMed ID: 37322811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing adherence to allopurinol for gout: patients' perspectives.
    Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL
    Br J Clin Pharmacol; 2023 Jul; 89(7):1978-1991. PubMed ID: 36607199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.
    Keenan RT
    Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experiences and perspectives of people with gout on urate self-monitoring.
    Michael TJF; Chan JS; Hughes S; Wright DFB; Coleshill MJ; Hughes DA; Day RO; Aslani P; Stocker SL
    Health Expect; 2024 Jun; 27(3):e14071. PubMed ID: 38742836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming adherence issues and other barriers to optimal care in gout.
    Nasser-Ghodsi N; Harrold LR
    Curr Opin Rheumatol; 2015 Mar; 27(2):134-8. PubMed ID: 25633242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
    Doherty M; Jenkins W; Richardson H; Sarmanova A; Abhishek A; Ashton D; Barclay C; Doherty S; Duley L; Hatton R; Rees F; Stevenson M; Zhang W
    Lancet; 2018 Oct; 392(10156):1403-1412. PubMed ID: 30343856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
    Robinson PC; Horsburgh S
    Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gout].
    Tausche AK
    Internist (Berl); 2021 May; 62(5):513-525. PubMed ID: 33721041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol: insights from studies of dose-response relationships.
    Day RO; Kannangara DR; Stocker SL; Carland JE; Williams KM; Graham GG
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):449-462. PubMed ID: 27927043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing medication adherence in patients with gout: A descriptive correlational study.
    Chua XHJ; Lim S; Lim FP; Lim YNA; He HG; Teng GG
    J Clin Nurs; 2018 Jan; 27(1-2):e213-e222. PubMed ID: 28618105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model.
    Hill-McManus D; Marshall S; Soto E; Lane S; Hughes D
    Value Health; 2018 Dec; 21(12):1373-1381. PubMed ID: 30502780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient factors and health outcomes associated with illness perceptions in people with gout.
    Selvadurai D; Coleshill MJ; Day RO; Briggs NE; Schulz M; Reath J; Aung E
    Rheumatology (Oxford); 2024 Jul; 63(7):1927-1937. PubMed ID: 37769230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
    Corbett EJM; Pentony P; McGill NW
    Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health literacy in patients dealing with gout: a qualitative study.
    van Onna M; Hinsenveld E; de Vries H; Boonen A
    Clin Rheumatol; 2015 Sep; 34(9):1599-603. PubMed ID: 25501463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.